๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Localized immunosuppression for pulmonary transplants

โœ Scribed by J. Maxwell Anderson; G. Hannah; M. G. Neely; J. Hutchison

Publisher
John Wiley and Sons
Year
1969
Tongue
English
Weight
454 KB
Volume
56
Category
Article
ISSN
0007-1323

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Tolerance for immunosuppression in organ
Tolerance for immunosuppression in organ transplantation
โœ Mark D. Stegall; Jeffrey L. Platt ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 63 KB

Background: Insight into the mechanisms of organ engraftment and acquired tolerance has made it possible to facilitate these mechanisms, by tailoring the timing and dosage of immunosuppression in accordance with two therapeutic principles: recipient pretreatment and minimum use of posttransplant imm

Future prospects in immunosuppression fo
Future prospects in immunosuppression for liver transplantation
โœ John J. Fung; Jessica E. Bollinger; Charles Miller; Bijan Eghtesad ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 100 KB

## Key Points 1. Our increasing understanding of signaling pathways and cellular interactions in transplant immunobiology and the availability of novel immunosuppressive agents have facilitated targeted strategies. 2. The driving forces behind the development of new immunosuppressive regimens are t

Sirolimus-based immunosuppression follow
Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma
โœ Michael A. Zimmerman; James F. Trotter; Michael Wachs; Tom Bak; Jeffrey Campsen; ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 124 KB

Experience with sirolimus (SRL)-based immunosuppression following orthotopic liver transplantation (OLT) is rapidly accumulating. In combination with calcineurin inhibitors (CNIs), SRL may reduce the incidence of acute rejection and lower overall required drug levels. This study sought to quantify l